| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/17/2012 | US8097275 External skin patch |
| 01/17/2012 | US8097274 Skin substitutes, preparation methods and uses thereof |
| 01/17/2012 | US8097272 Layered materials for use as wound dressings |
| 01/17/2012 | US8097271 Warming compositions and delivery systems therefor |
| 01/17/2012 | US8097270 Use of nanoparticles as carriers for biocides in ophthalmic compositions |
| 01/17/2012 | US8097262 Gel type enteral nutrient |
| 01/17/2012 | US8097247 Probiotic, lactic acid-producing bacteria and uses thereof |
| 01/17/2012 | US8096987 Methods and apparatus for translating a continuous-delivery into a plurality of periodic bolus deliveries |
| 01/17/2012 | US8096972 Devices for intraocular drug delivery |
| 01/17/2012 | CA2561361C Crosslinkable pressure-sensitive adhesive for the skin |
| 01/17/2012 | CA2527419C Novel lipid mixtures for synthetic surfactants |
| 01/17/2012 | CA2499597C Multistage formulation containing a biguanide and thiazolidindione derivatives |
| 01/17/2012 | CA2489269C Composition for treatment of inflammatory disorders |
| 01/17/2012 | CA2474742C Dermal access member |
| 01/17/2012 | CA2429998C Intraocular implants for preventing transplant rejection in the eye |
| 01/17/2012 | CA2379180C Methods for suppressing appetite and enhancing exercise and recovery |
| 01/17/2012 | CA2345208C Protective recombinant haemophilus influenzae high molecular weight proteins |
| 01/12/2012 | WO2012006612A2 Use of trans-palmitoleate in identifying and treating metabolic disease |
| 01/12/2012 | WO2012006398A2 Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
| 01/12/2012 | WO2012006380A2 Cationic oil-in-water emulsions |
| 01/12/2012 | WO2012006378A1 Liposomes with lipids having an advantageous pka- value for rna delivery |
| 01/12/2012 | WO2012006359A1 Delivery of self-replicating rna using biodegradable polymer particles |
| 01/12/2012 | WO2012006298A2 Formulation for co-therapy treatment of diabetes |
| 01/12/2012 | WO2012006218A1 Chewing gum containing a cross-linked gelatin matrix gum base |
| 01/12/2012 | WO2012006169A2 Compositions and methods for enhancement of nucleic acid delivery |
| 01/12/2012 | WO2012006101A2 Blood substitutes and uses thereof |
| 01/12/2012 | WO2012006081A1 Oral formulation of kinase inhibitors |
| 01/12/2012 | WO2012005709A2 Pharmaceutical composition comprising valsartan |
| 01/12/2012 | WO2012005594A2 Biodegradable phase separated segmented multi block co-polymers and release of biologically active polypeptides |
| 01/12/2012 | WO2012005500A2 Time-delayed sustained release pharmaceutical composition comprising dapoxetine for oral administration |
| 01/12/2012 | WO2012005376A1 Composition for nucleic acid delivery, carrier composition, pharmaceutical composition using the composition for nucleic acid delivery or the carrier composition, and method for delivering nucleic acid |
| 01/12/2012 | WO2012005365A1 Particle coating preparation |
| 01/12/2012 | WO2012005359A1 Orally disintegrating tablet |
| 01/12/2012 | WO2012005340A1 Tablet containing ferric citrate |
| 01/12/2012 | WO2012005311A1 Composition for contact lens care |
| 01/12/2012 | WO2012004966A1 Therapeutic agent for fibromyalgia containing etanercept |
| 01/12/2012 | WO2012004726A1 Trans-epithelial osmotic collyrium for the treatment of keratoconus |
| 01/12/2012 | WO2012004691A2 Pharmaceutical formulations of rasagiline |
| 01/12/2012 | WO2012004438A1 Injectable pharmaceutical formulation of melphalan |
| 01/12/2012 | WO2012004399A1 Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis |
| 01/12/2012 | WO2012004308A1 Stable aqueous formulations comprising poorly water soluble active ingredients |
| 01/12/2012 | WO2012004291A1 Improved method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmaceutical active ingredients. |
| 01/12/2012 | WO2012004239A1 Method for dosing a fluid formulation containing a medicinal substance |
| 01/12/2012 | WO2012004231A1 Dosage form |
| 01/12/2012 | WO2012003987A1 Oral dosage form of deferasirox |
| 01/12/2012 | WO2012003968A1 Novel gastro- retentive dosage forms comprising a gaba analog and an opioid |
| 01/12/2012 | WO2012003960A1 Topical application of erythropoietin for the treatment of eye disorders and injuries |
| 01/12/2012 | WO2012003814A1 Vaccine compositions based on sticholysin encapsulated in liposomes |
| 01/12/2012 | WO2012003804A1 Pharmaceutical composition of silybin and preparation method thereof |
| 01/12/2012 | WO2012003768A1 Semen cassiae soft capsule for reducing fat and losing weight and preparation method thereof |
| 01/12/2012 | WO2012003737A1 Method for preparing animal semen freeze-dried powder |
| 01/12/2012 | WO2012003704A1 Sodium alginate crosslinked slow-released moxiflorxacin microsphere, the preparation method and the use thereof, and target vascular occlusive agent of the microsphere |
| 01/12/2012 | WO2011148253A3 Solid dosage forms of antipsychotics |
| 01/12/2012 | WO2011146595A3 Zwitterionic reagents |
| 01/12/2012 | WO2011139420A3 Propynylaminoindan transdermal compositions |
| 01/12/2012 | WO2011119929A3 Composition for enhancing athletic performance |
| 01/12/2012 | WO2011119585A3 Aerosol foams comprising clindamycin phosphate |
| 01/12/2012 | WO2011118958A3 Oil-in-water type nano-emulsion composition and method for preparing same |
| 01/12/2012 | WO2011116738A3 Novel support system for the transport of active substances into the skin |
| 01/12/2012 | WO2011116020A3 Ophthalmic formulations of cetirizine and methods of use |
| 01/12/2012 | WO2011115778A9 Aerosolized dapsone as a therapy for inflammation of the airway and abnormal mucociliary transport |
| 01/12/2012 | WO2011112900A3 Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
| 01/12/2012 | WO2011112797A3 Silky-feeling non-aqueous structured composition |
| 01/12/2012 | WO2011112793A3 Non-aqueous structured compositions |
| 01/12/2012 | WO2011111068A3 Gastroretentive, extended release composition of therapeutic agent |
| 01/12/2012 | WO2011110407A3 Micelle compositions and process for the preparation thereof |
| 01/12/2012 | WO2011110347A3 Compositions for colon lavage and methods of making and using same |
| 01/12/2012 | WO2011109745A3 Compositions and methods for treating parasitic disease |
| 01/12/2012 | WO2011108882A3 Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient |
| 01/12/2012 | WO2011105835A3 Method and apparatus for preparing novel liposome |
| 01/12/2012 | WO2011103413A3 Taxane pro-emulsion formulations and methods making and using the same |
| 01/12/2012 | WO2011102657A3 Composition for percutaneous administration of tolterodine with improved skin permeation |
| 01/12/2012 | WO2011097546A3 Topical antibiotic formulations |
| 01/12/2012 | WO2011087765A3 Methods of producing stabilized solid pharmaceutical compositions containing morphinans |
| 01/12/2012 | WO2011068872A3 Carboxyvinyl polymer-containing nanoparticle suspension |
| 01/12/2012 | WO2011058336A3 Tablet comprising gum arabic |
| 01/12/2012 | WO2011048613A3 Emergency contraceptive |
| 01/12/2012 | WO2011047173A3 Pharmaceutical compositions for oral administration |
| 01/12/2012 | WO2011042077A3 Transdermal therapeutic systems containing 4-n-butylresorcinol |
| 01/12/2012 | WO2010134048A3 Topical retinoid solutions |
| 01/12/2012 | WO2010072958A3 Topical pharmaceutical composition containing a water-sensitive active principle |
| 01/12/2012 | US20120010599 Inorganically surface-modified polymers and methods for making and using them |
| 01/12/2012 | US20120010557 Drug Delivery System for Use in the Treatment of Vascular and Vessel-Related Pathologies |
| 01/12/2012 | US20120010258 Additional therapeutic use |
| 01/12/2012 | US20120010218 Formulations |
| 01/12/2012 | US20120010215 Treatment of bacterial diseases of the respiratory organs |
| 01/12/2012 | US20120009325 Method of Making a Stent with Hollow Struts |
| 01/12/2012 | US20120009272 Compositions and methods for creating an air release mechanism to maintain skin health |
| 01/12/2012 | US20120009268 Modified Virus Vectors and Methods of Making and Using the Same |
| 01/12/2012 | US20120009267 Nanoparticle compositions and methods for improved oral delivery of active agents |
| 01/12/2012 | US20120009266 Composition comprising ocaperidone |
| 01/12/2012 | US20120009265 Drug carrier |
| 01/12/2012 | US20120009264 Drug carrier for treating of gastrointestinal ulcer |
| 01/12/2012 | US20120009263 Granular delivery system |
| 01/12/2012 | US20120009262 Medical apparatus and method for producing same |
| 01/12/2012 | US20120009261 Novel gastro-retentive dosage forms |
| 01/12/2012 | US20120009260 Nanoparticle film delivery systems |
| 01/12/2012 | US20120009259 Formulation for co-therapy treatment of diabetes |
| 01/12/2012 | US20120009258 Compacted cinacalcet |
| 01/12/2012 | US20120009257 Galenical Formulations of a Fixed Dose Combination of Valsartan and Aliskiren |